Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-25T22:39:21.779Z Has data issue: false hasContentIssue false

FC19-06 - Visual backward masking - an excellent endophenotype for Schizophrenia ?

Published online by Cambridge University Press:  16 April 2020

G. Bakanidze
Affiliation:
Department of Psychiatry, Charité (CCM), Berlin, Germany
M. Roinishvili
Affiliation:
Department of Behaviour and Cognitive Functions, I. Beritashvili Institute of Physiology, Georgia
E. Chkonia
Affiliation:
Department of Psychiatry, Tbilisi State Medical University, Tbilisi, Georgia
M.H. Herzog
Affiliation:
Laboratory of Psychophysics, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
A. Brand
Affiliation:
Klinikum Bremen-Ost, Center for Psychiatry and Psychotherapy, Bremen, Germany
I. Puls
Affiliation:
Department of Psychiatry, Charité (CCM), Berlin, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Due to the complexity of psychiatric diseases, endophenotypes are of primary interest in psychiatric research. They are stable markers which are assumed to be related to a small number of genes involved in the pathophysiology of the disease. Visual backward masking (BM), like other parameters measuring early information processing, was proposed to be a reliable marker for schizophrenia. Performance deficits in BM are considerably more pronounced in schizophrenic patients and their unaffected relatives compared to controls. As shown before, in the present study BM performance was significantly worse in schizophrenic patients compared to controls; healthy relatives of schizophrenic patients performed intermediately.

Several candidate genes for schizophrenia including nicotinic receptor α7 subunit (CHRNA7), catechol-O-methyltransferase (COMT), dystrobrevin-binding protein 1 (dysbindin, DTNBP1) and metabotropic glutamate receptor 3 gene (GRM3) were investigated for their association with schizophrenia and BM in two independent samples. A strong and reproducible association was observed for CHRNA7 with both diagnosis of schizophrenia and BM performance. In conclusion, BM is an excellent endophenotype which will likely support the search for further candidate genes and related pathophysiological pathways in schizophrenia. Moreover, CHRNA7 has further supported its important role as one of the main candidate genes for schizophrenia.

Type
Research Article
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.